276 related articles for article (PubMed ID: 23827424)
1. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
3. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
[TBL] [Abstract][Full Text] [Related]
5. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
6. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neurofilament and glial fibrillary acidic protein in patients with cerebral vasculitis.
Nylén K; Karlsson JE; Blomstrand C; Tarkowski A; Trysberg E; Rosengren LE
J Neurosci Res; 2002 Mar; 67(6):844-51. PubMed ID: 11891800
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases.
Constantinescu R; Mahamud U; Constantinescu C; Eriksson B; Novakova L; Olsson B; Rosengren L; Blennow K; Axelsson M
Acta Neurol Scand; 2019 Sep; 140(3):177-183. PubMed ID: 31087810
[TBL] [Abstract][Full Text] [Related]
9. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
10. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E; Nylen K; Rosengren LE; Tarkowski A
Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
[TBL] [Abstract][Full Text] [Related]
11. Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Mañé-Martínez MA; Olsson B; Bau L; Matas E; Cobo-Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
J Neuroimmunol; 2016 Oct; 299():112-117. PubMed ID: 27725108
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Rosén C; Rosén H; Andreasson U; Bremell D; Bremler R; Hagberg L; Rosengren L; Blennow K; Zetterberg H
Resuscitation; 2014 Feb; 85(2):227-32. PubMed ID: 24231570
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
[TBL] [Abstract][Full Text] [Related]
14. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
15. Non-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity.
Anckarsäter R; Anckarsäter H; Bromander S; Blennow K; Wass C; Zetterberg H
J Neural Transm (Vienna); 2014 Jun; 121(6):649-53. PubMed ID: 24420082
[TBL] [Abstract][Full Text] [Related]
16. Is there a CSF biomarker profile related to depression in elderly women?
Gudmundsson P; Skoog I; Waern M; Blennow K; Zetterberg H; Rosengren L; Gustafson D
Psychiatry Res; 2010 Apr; 176(2-3):174-8. PubMed ID: 20132991
[TBL] [Abstract][Full Text] [Related]
17. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities.
Kristjánsdóttir R; Uvebrant P; Rosengren L
Neuropediatrics; 2001 Dec; 32(6):307-12. PubMed ID: 11870586
[TBL] [Abstract][Full Text] [Related]
18. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim AT; Malm J
Acta Neurol Scand; 2007 Nov; 116(5):333-9. PubMed ID: 17922727
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome.
Lindström J; Grahn A; Zetterberg H; Studahl M
Eur J Neurosci; 2016 Dec; 44(11):2944-2949. PubMed ID: 27643680
[TBL] [Abstract][Full Text] [Related]
20. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
